1-11 of 11
Maria Rosa Bani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4838: Exploiting mitochondrial metabolism to enhance the response to standard of care treatments in ovarian cancer

Laura Formenti, Alessandra Decio, Valentina Dematteis, Giulia Dellavedova, Maria Rosa Bani, Raffaella Giavazzi, Carmen Ghilardi
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4838.
https://doi.org/10.1158/1538-7445.AM2023-4838
Published: 04 April 2023
View article titled, Abstract 4838: Exploiting mitochondrial metabolism to enhance the response to standard of care treatments in ovarian cancer
Journal Articles

Abstract 6113: Predictive value of HRD testing on the response to PARP inhibitors in ovarian cancer preclinical models

Giulia Dellavedova, Alessandra Decio, Laura Formenti, Luca Porcu, Carmen Ghilardi, Raffaella Giavazzi, Maria Rosa Bani
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6113.
https://doi.org/10.1158/1538-7445.AM2023-6113
Published: 04 April 2023
View article titled, Abstract 6113: Predictive value of HRD testing on the response to PARP inhibitors in ovarian cancer preclinical models
Journal Articles

Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer

Francesca Falcetta, Francesca Bizzaro, Elisa D'Agostini, Maria Rosa Bani, Raffaella Giavazzi, Paolo Ubezio
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6759–6769.
https://doi.org/10.1158/0008-5472.CAN-17-1099
Published: 30 November 2017
View article titled, Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer
Open the PDF for Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Francesca Ricci, Francesca Bizzaro, Marta Cesca, Federica Guffanti, Monica Ganzinelli, Alessandra Decio, Carmen Ghilardi, Patrizia Perego, Robert Fruscio, Alessandro Buda, Rodolfo Milani, Paola Ostano, Giovanna Chiorino, Maria Rosa Bani, Giovanna Damia, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6980–6990.
https://doi.org/10.1158/0008-5472.CAN-14-0274
Published: 30 November 2014
View article titled, Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Open the PDF for Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations in another window
Includes: Supplementary data
Journal Articles

Abstract 5096: Heterogeneous response to antiangiogenic therapy in ovarian cancer xenografts: a tool to investigate biomarkers of resistance.

Alessandra Decio, Marta Cesca, Francesca Bizzaro, Valentina Scarlato, Carmen Ghilardi, Maria Rosa Bani, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5096.
https://doi.org/10.1158/1538-7445.AM2013-5096
Published: 15 April 2013
View article titled, Abstract 5096: Heterogeneous response to antiangiogenic therapy in ovarian cancer xenografts: a tool to investigate biomarkers of resistance.
Journal Articles

Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin–Positive Metastatic Human Melanoma Xenografts

Michele Moschetta, Francesca Pretto, Alexander Berndt, Kerstin Galler, Petra Richter, Andrea Bassi, Paolo Oliva, Edoardo Micotti, Giovanni Valbusa, Kathrin Schwager, Manuela Kaspar, Eveline Trachsel, Hartwig Kosmehl, Maria Rosa Bani, Dario Neri, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2012) 72 (7): 1814–1824.
https://doi.org/10.1158/0008-5472.CAN-11-1919
Published: 01 April 2012
View article titled, Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin–Positive Metastatic Human Melanoma Xenografts
Open the PDF for Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin–Positive Metastatic Human Melanoma Xenografts in another window
Includes: Supplementary data
Journal Articles

Abstract 3516: Combinations of chemotherapy with bevacizumab in a xenograft model of human ovarian carcinoma

Paolo Oliva, Alessandra Decio, Vittoria Castiglioni, Andrea Bassi, Dorina Belotti, Maria Rosa Bani, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3516.
https://doi.org/10.1158/1538-7445.AM2011-3516
Published: 15 April 2011
View article titled, Abstract 3516: Combinations of chemotherapy with bevacizumab in a xenograft model of human ovarian carcinoma
Journal Articles

Modulation of Tumor Angiogenesis by Conditional Expression of Fibroblast Growth Factor-2 Affects Early but not Established Tumors

Raffaella Giavazzi, Roberta Giuliani, Daniela Coltrini, Maria Rosa Bani, Cristina Ferri, Barbara Sennino, Maria Pia Molinari Tosatti, Antonella Stoppacciaro, Marco Presta
Journal: Cancer Research
Cancer Res (2001) 61 (1): 309–317.
Published: 01 January 2001
View article titled, Modulation of Tumor Angiogenesis by Conditional Expression of Fibroblast Growth Factor-2 Affects Early but not Established Tumors
Open the PDF for Modulation of Tumor Angiogenesis by Conditional Expression of Fibroblast Growth Factor-2 Affects Early but not Established Tumors in another window
Journal Articles

Multiple Features of Advanced Melanoma Recapitulated in Tumorigenic Variants of Early Stage (Radial Growth Phase) Human Melanoma Cell Lines: Evidence for a Dominant Phenotype

Maria Rosa Bani, Janusz Rak, Dena Adachi, Rodney Wiltshire, Jeffrey M. Trent, Robert S. Kerbel, Yaacov Ben-David
Journal: Cancer Research
Cancer Res (1996) 56 (13): 3075–3086.
Published: 01 July 1996
View article titled, Multiple Features of Advanced Melanoma Recapitulated in Tumorigenic Variants of Early Stage (Radial Growth Phase) Human Melanoma Cell Lines: Evidence for a Dominant Phenotype
Open the PDF for Multiple Features of Advanced Melanoma Recapitulated in Tumorigenic Variants of Early Stage (Radial Growth Phase) Human Melanoma Cell Lines: Evidence for a Dominant Phenotype in another window
Journal Articles

The 92-kDa Gelatinase B Is Expressed by Advanced Stage Melanoma Cells: Suppression by Somatic Cell Hybridization with Early Stage Melanoma Cells

John R. MacDougall, Maria Rosa Bani, Yulia Lin, Janusz Rak, Robert S. Kerbel
Journal: Cancer Research
Cancer Res (1995) 55 (18): 4174–4181.
Published: 01 September 1995
View article titled, The 92-kDa Gelatinase B Is Expressed by Advanced Stage Melanoma Cells: Suppression by Somatic Cell Hybridization with Early Stage Melanoma Cells
Open the PDF for The 92-kDa Gelatinase B Is Expressed by Advanced Stage Melanoma Cells: Suppression by Somatic Cell Hybridization with Early Stage Melanoma Cells in another window
Journal Articles

Interleukin 1-induced Augmentation of Experimental Metastases from a Human Melanoma in Nude Mice

Raffaella Giavazzi, Angela Garofalo, Maria Rosa Bani, Mauro Abbate, Pietro Ghezzi, Diana Boraschi, Alberto Mantovani, Elisabetta Dejana
Journal: Cancer Research
Cancer Res (1990) 50 (15): 4771–4775.
Published: 01 August 1990
View article titled, Interleukin 1-induced Augmentation of Experimental Metastases from a Human Melanoma in Nude Mice
Open the PDF for Interleukin 1-induced Augmentation of Experimental Metastases from a Human Melanoma in Nude Mice in another window